EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA: Empiric glycopeptide use in neutropenic fever. Mediterr J Hematol Infect Dis [Internet]. 2022 Apr. 28 [cited 2026 Jun. 5];14(1):e2022039. Available from: https://www.mjhid.org/mjhid/article/view/4942